Market Cap 173.44B
Revenue (ttm) 44.56B
Net Income (ttm) 6.70B
EPS (ttm) N/A
PE Ratio 22.47
Forward PE 20.82
Profit Margin 15.05%
Debt to Equity Ratio 0.67
Volume 2,684,500
Avg Vol 2,134,634
Day's Range N/A - N/A
Shares Out 371.62M
Stochastic %K 17%
Beta 0.97
Analysts Strong Sell
Price Target $651.33

Company Profile

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; d...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 622 1000
Address:
168 Third Avenue, Waltham, United States
DynamicSupportWorkspace
DynamicSupportWorkspace Apr. 24 at 2:52 PM
$TMO healthcare tools leader with strong recurring demand and stable execution
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Apr. 24 at 1:51 PM
$TMO Medical device is dead $$$ AI will replace 30% of their business
0 · Reply
green_going_up
green_going_up Apr. 23 at 10:43 PM
$TMO $DHR the question is really whether AI will create LESS need for their products and a lower # of clinical trial work - if you can run the analytics to eliminate certain molecules or combinations of molecules that have no chance in working - or MORE need for their products - if the AI provides a greater number of molecules or combinations of molecules to test in humans. If AI enables future cures of diseases, then surely, there will be less aggregate demand for testing equipment over time.
2 · Reply
Marcos_Crawler
Marcos_Crawler Apr. 23 at 7:04 PM
0 · Reply
thefourpercent
thefourpercent Apr. 23 at 5:50 PM
$TMO will do a couple % soon
0 · Reply
JazzPaw
JazzPaw Apr. 23 at 4:50 PM
$TMO Weird sell off but I’ll wait for a bottom. $400 would be nice, $600 is too high. The rest is the market.
0 · Reply
MrYassine
MrYassine Apr. 23 at 4:39 PM
$TMO this should have us all salivating. At this price its an absolute buy.
0 · Reply
etradebaby
etradebaby Apr. 23 at 4:20 PM
$TMO geez
0 · Reply
parr
parr Apr. 23 at 3:52 PM
$TMO Whale dumping? Why the sudden drop. This is a quality company.
0 · Reply
PanicSeller8
PanicSeller8 Apr. 23 at 3:21 PM
$TMO If I believed in charts, I'd say this 460ish area needs to hold in days ahead because 415 looks like next support base.
0 · Reply
Latest News on TMO
Thermo Fisher Scientific Reports First Quarter 2026 Results

Apr 23, 2026, 6:00 AM EDT - 1 day ago

Thermo Fisher Scientific Reports First Quarter 2026 Results


Thermo Fisher Scientific Increases Quarterly Dividend

Feb 25, 2026, 4:15 PM EST - 2 months ago

Thermo Fisher Scientific Increases Quarterly Dividend


5 Oversold Stocks to Buy Before They Rebound

Feb 23, 2026, 10:59 AM EST - 2 months ago

5 Oversold Stocks to Buy Before They Rebound

AMZN LPLA MSFT PANW


Josh Brown's ‘best stocks in the market': Health Care

Nov 24, 2025, 1:50 PM EST - 5 months ago

Josh Brown's ‘best stocks in the market': Health Care

A LLY MTD XLV


The Big 3: TMO, DHR, VLO

Nov 13, 2025, 12:50 PM EST - 5 months ago

The Big 3: TMO, DHR, VLO

DHR VLO


Thermo Fisher Scientific Declares Quarterly Dividend

Nov 6, 2025, 4:30 PM EST - 6 months ago

Thermo Fisher Scientific Declares Quarterly Dividend


DynamicSupportWorkspace
DynamicSupportWorkspace Apr. 24 at 2:52 PM
$TMO healthcare tools leader with strong recurring demand and stable execution
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Apr. 24 at 1:51 PM
$TMO Medical device is dead $$$ AI will replace 30% of their business
0 · Reply
green_going_up
green_going_up Apr. 23 at 10:43 PM
$TMO $DHR the question is really whether AI will create LESS need for their products and a lower # of clinical trial work - if you can run the analytics to eliminate certain molecules or combinations of molecules that have no chance in working - or MORE need for their products - if the AI provides a greater number of molecules or combinations of molecules to test in humans. If AI enables future cures of diseases, then surely, there will be less aggregate demand for testing equipment over time.
2 · Reply
Marcos_Crawler
Marcos_Crawler Apr. 23 at 7:04 PM
0 · Reply
thefourpercent
thefourpercent Apr. 23 at 5:50 PM
$TMO will do a couple % soon
0 · Reply
JazzPaw
JazzPaw Apr. 23 at 4:50 PM
$TMO Weird sell off but I’ll wait for a bottom. $400 would be nice, $600 is too high. The rest is the market.
0 · Reply
MrYassine
MrYassine Apr. 23 at 4:39 PM
$TMO this should have us all salivating. At this price its an absolute buy.
0 · Reply
etradebaby
etradebaby Apr. 23 at 4:20 PM
$TMO geez
0 · Reply
parr
parr Apr. 23 at 3:52 PM
$TMO Whale dumping? Why the sudden drop. This is a quality company.
0 · Reply
PanicSeller8
PanicSeller8 Apr. 23 at 3:21 PM
$TMO If I believed in charts, I'd say this 460ish area needs to hold in days ahead because 415 looks like next support base.
0 · Reply
flbulltrader
flbulltrader Apr. 23 at 3:04 PM
$TMO new position here!
0 · Reply
profit_guru
profit_guru Apr. 23 at 2:24 PM
$TMO - solid guidance provided on conference call…might rally above 490…imo
0 · Reply
nio11
nio11 Apr. 23 at 1:37 PM
$TMO anyone buying on this ER result?
1 · Reply
chicken_banana
chicken_banana Apr. 23 at 1:33 PM
$TMO what a great opportunity to buy. This market is ridiculous
0 · Reply
Following_the_trend
Following_the_trend Apr. 23 at 1:16 PM
$TMO Looks like I may bottom fish in quality today.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 23 at 10:13 AM
$TMO Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $4.44 up 11.28% YoY • Reported revenue of $11.01B up 6.18% YoY
0 · Reply
smartkarma
smartkarma Apr. 23 at 10:05 AM
📈 Earnings Alert $TMO - Thermo Fisher 1Q Adj EPS Beats Estimates: ∙ Adj EPS $5.44 vs. $5.15 y/y, est $5.24 ∙ Revenue $11.01b, +6.2% y/y, est $10.85b ∙ Life sciences revenue $2.64b, +13% y/y, est $2.61b https://www.smartkarma.com/entities/thermo-fisher-scientific-inc
0 · Reply
buddyopalosam
buddyopalosam Apr. 22 at 11:42 PM
$TMO the way its been yrading seems like gonna be a miss on the earnings and information has leaked. We will see
0 · Reply
stockwatcherking
stockwatcherking Apr. 22 at 8:42 PM
$TMO I like this as a long going into ER. 100% beat rate (avg +2.66% surprise), 9 bullish vs 1 bearish flow alerts, IV rank 59 acceptable for long calls. Strong flow AND perfect beat history with only +3% from 50DMA offers room to run.
1 · Reply
DonCorleone77
DonCorleone77 Apr. 22 at 8:22 PM
$TMO $HON $LMT $AAL $FCX Some notable companies reporting before tomorrow's open, with earnings consensus estimates: - Thermo Fisher (TMO), consensus $5.24 - Honeywell (HON), consensus $2.32 - Lockheed Martin (LMT), consensus $6.74 - America Airlines (AAL), consensus (46c) - Huntington Bancshares (HBAN), consensus 35c - Freeport McMoRan (FCX), consensus 47c - Blackstone (BX), consensus $1.34 - American Express (AXP), consensus $3.99 - Union Pacific (UNP), consensus $2.86 - Comcast (CMCSA), consensus 73c - CenterPoint Energy (CNP), consensus 57c
0 · Reply
NasdaqPulse
NasdaqPulse Apr. 21 at 8:22 PM
New liquidity just hit the tape — and most traders aren’t paying attention yet 👉Click to view @NasdaqPulse for timely updates amid the volatility. BybitTradFi just rolled out 45 new equities, opening the door for global capital to rotate into names that were previously harder to access on that platform. More access = more flow, and flow is what moves price. Watch the early movers: $PINS catching social media momentum, $NVAX bringing biotech volatility back into play, $SCHW tied to rate sentiment and retail flows, and $TMO representing high-quality exposure to the science/healthcare complex. Different sectors, same theme — fresh eyes + fresh liquidity. And don’t ignore the incentive structure — small credits like $5 on a $10 trade might sound minor, but they’re designed to drive engagement and volume spikes in the early phase. New listings often create short-term inefficiencies. Smart money watches where the volume clusters first.
0 · Reply
StocktwitsNews
StocktwitsNews Apr. 21 at 8:40 AM
SLS Stock Jumps Premarket: US Investor Dagco Boosts Stake By 78% Ahead Of Fresh Cancer Drug Data Reveal $SLS $JNJ $MRK $TMO https://stocktwits.com/news/equity/markets/sls-stock-premarket-dagco-raises-stake-ahead-of-aacr-leukemia-data/cZBIfhbRICL
0 · Reply